We are live on
!
Find out more
ESPR
Esperion Therapeutics
ESPR
ESPR
Delisted
ESPR was delisted on the 10th of July, 2026.
142 hedge funds and large institutions have $598M invested in Esperion Therapeutics in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 42 increasing their positions, 45 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 45
2.2% less ownership
Funds ownership: 102.73% → 100.53% (-2.2%)
8% less funds holding
Funds holding: 155 → 142 (-13)
26% less capital invested
Capital invested by funds: $805M → $598M (-$206M)
30% less call options, than puts
Call options by funds: $14.9M | Put options by funds: $21.3M
42% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 31
Holders
142
Holders Change
-13
Holders Change %
-8.39%
% of All Funds
2.47%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
18
Increased
42
Reduced
45
Closed
31
Calls
$14.9M
Puts
$21.3M
Net Calls
-$6.37M
Net Calls Change
+$5.21M
Top Buyers
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$12.8M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$9.63M |
| 3 |
Morgan Stanley
New York
|
+$6.71M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$3.43M |
| 5 |
MG
Meditor Group
Hamilton,
Bermuda
|
+$3.35M |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$18.2M |
| 2 |
BAMCO Inc
New York
|
-$10.5M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$8.46M |
| 4 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$7.67M |
| 5 |
Axa
Paris,
France
|
-$3.57M |
